1Bingel U, Wanigasekera V, Wiech K, et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil[ J]. Sei Transl Med, 2011, 3 (70) : 70ra14.
2Jensen KB, Kaptchuk TJ, Kirsch I, et al. Nonconscious activation of placebo and nocebo pain responses [ J ]. Proc Natl Acad Sci U S A, 2012, 109(39) : 15959-15964.
3Colloca L, Benedetti F. How prior experience shapes placebo analgesia[Jl. Pain, 2006, 124(1-2): 126-133.
4Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia[J]. Lancet, 1978, 2(8091 ) : 654-657.
5Lipman JJ, Miller BE, Mays KS, et al. Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response [ J ]. Psyehopharmacology (Berl) , 1990, 102(1): 112-116.
6Eippert F, Bingel U, Scboell ED, et al. Activation of the opioidergic descending pain control system underlies placebo analgesia[J]. Neuron, 2009, 63(4): 533-543.
7Noble F, Roques BP. The role of CCK2 receptors in the homeostasis of the opioid system [ J ]. Drugs Today ( Barc ) , 2003, 39(11) : 897-908.
8Pommier B, Beslot F, Simon A, et al. Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system [J]. J Neurosei, 2002, 22(5) : 2005-2011.
9de la Fuente-Fernandez R, Phillips AG, Zamburlini M, et al. Dopamine release in human ventral striatum and expectation of reward[J]. Behav Brain Res. 2002. 136(2) : 359-363.
10Benedetti F, Amanzio M, Rosato R, et al. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors [ J ]. Nat Med, 2011, 17(10): 1228-1230.
